Skip to content
PubMed This is a summary of 56 peer-reviewed journal articles Updated
Clinical Genetics · Type A Insulin Resistance Syndrome

Type A Insulin Resistance Syndrome: A Patient Guide

At a Glance

Type A Insulin Resistance Syndrome is a rare inherited condition caused by an INSR gene mutation. It can cause severe insulin resistance, high insulin, blood sugar swings, acanthosis nigricans, and reproductive symptoms, so diagnosis supports personalized care.

Type A Insulin Resistance Syndrome (TAIRS) is a rare genetic condition that fundamentally changes how your body interacts with one of its most vital hormones: insulin. In a typical metabolic system, insulin acts like a key that opens “locks” called insulin receptors on the surface of your cells, allowing sugar to enter and provide energy. For those living with TAIRS, a mutation in the INSR gene means these locks have a defect that reduces their function, preventing the signal from getting through [1]. This leads to a state of extreme insulin resistance where the body produces massive amounts of the hormone to compensate, yet the cells remain unable to respond effectively [2].

Because this condition is genetic rather than lifestyle-driven, it follows a unique pattern that often confuses standard medical assessments. While TAIRS can affect individuals across the weight spectrum, being naturally lean is a frequent clue [3]. The symptoms often become most apparent during puberty, particularly for females, who may experience irregular menstrual cycles, persistent acne, and excess hair growth—a cluster of signs that leads many to be misdiagnosed for years with Polycystic Ovary Syndrome (PCOS) [4]. A hallmark physical sign of the condition is acanthosis nigricans, where the skin in areas like the neck and armpits becomes dark and velvety due to the high levels of insulin circulating in the blood [1].

Living with TAIRS often involves navigating a metabolic paradox known as the “dual nature” of blood sugar. While you may experience high blood sugar because your cells cannot absorb glucose, you are also at risk for sudden “crashes,” or postprandial hypoglycemia, a few hours after eating [5]. This happens because the enormous surge of insulin produced after a meal can eventually overpower the resistance, causing blood sugar to drop rapidly [6]. Understanding this cycle is essential for managing your daily energy and long-term health.

While a diagnosis of a rare genetic disorder can feel overwhelming, it provides a clear roadmap that was previously missing. Identifying the specific INSR mutation allows your medical team to move beyond general diabetes advice and toward a specialized plan that addresses your unique biology [7]. By focusing on stabilizing blood sugar swings and managing hormonal symptoms, you can work toward a balanced life with a care team that understands the specific challenges of your condition [8].

Common questions in this guide

What causes Type A Insulin Resistance Syndrome?
TAIRS is caused by a mutation in the INSR gene, which provides instructions for an insulin receptor on cells. The altered receptor does not transmit insulin's signal normally, so the body may produce very high insulin levels while cells remain resistant. It is genetic rather than caused by diet or lifestyle.
What signs can suggest that I have TAIRS?
Possible signs include a naturally lean body type, dark velvety skin called acanthosis nigricans, irregular periods, persistent acne, and excess hair growth. Symptoms often become more noticeable during puberty, especially in females, and may resemble PCOS.
Why can TAIRS cause both high blood sugar and crashes after meals?
TAIRS can cause high blood sugar because cells cannot take up glucose effectively. After eating, the body may release a very large amount of insulin; hours later, that insulin can lower blood sugar too far, causing postprandial hypoglycemia or a sudden crash.
How is TAIRS distinguished from PCOS?
A clinician may use genetic testing to look for an INSR mutation and compare the result with the overall symptom pattern. Severe insulin resistance, a lean body type, acanthosis nigricans, after-meal low blood sugar, and reproductive symptoms can prompt the care team to consider TAIRS rather than assuming the symptoms are only PCOS. The two conditions can have overlapping features, so interpretation should be individualized.
Which specialists may help manage Type A Insulin Resistance Syndrome?
A clinical geneticist can help interpret an INSR result, and a reproductive endocrinologist may help with menstrual or other hormonal concerns. Ongoing care may also include blood sugar monitoring and checks of cardiovascular and kidney health over time. The exact care team depends on your symptoms and needs.
Should my biological relatives be tested for TAIRS?
Because TAIRS is genetic, biological relatives may have a higher chance of carrying a related INSR variant. Ask a clinical genetics professional how to discuss the diagnosis and whether relatives should have genetic counseling or testing; relatives should not arrange testing based on a result without professional guidance.

Get notified when new evidence is published on Insulin-resistance syndrome type A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report.

    Lin L, Chen C, Fang T, et al.

    Journal of medical case reports 2019; (13(1)):347 doi:10.1186/s13256-019-2304-4.

    PMID: 31771632
  2. 2

    A New Mutation of the INSR Gene in a 13-Year-Old Girl with Severe Insulin Resistance Syndrome in China.

    Jin J, Liang X, Wei J, Xu L

    BioMed research international 2021; (2021()):8878149 doi:10.1155/2021/8878149.

    PMID: 33728347
  3. 3

    A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation.

    Ji C, Zheng X, Wang Q, Chen Z

    Frontiers in endocrinology 2026; (17()):1840942 doi:10.3389/fendo.2026.1840942.

    PMID: 42272804
  4. 4

    Arg1201Gln mutation of insulin receptor impairs tyrosine kinase activity and causes insulin resistance: a case report.

    Ding Q, Liang M

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2020; (36(6)):558-560 doi:10.1080/09513590.2019.1707794.

    PMID: 31899992
  5. 5

    Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance.

    Marcelino do Nascimento R, Dos Santos A, Guadagnini D, et al.

    Frontiers in endocrinology 2026; (17()):1716020 doi:10.3389/fendo.2026.1716020.

    PMID: 42181197
  6. 6

    Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion.

    Verdecchia F, Akcan N, Dastamani A, et al.

    Hormone research in paediatrics 2020; (93(6)):396-401 doi:10.1159/000510462.

    PMID: 33040071
  7. 7

    Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation

    Poon SWY, Chung BHY, Wong MSC, Tsang AMC

    Journal of clinical research in pediatric endocrinology 2025; (17(1)):115-119 doi:10.4274/jcrpe.galenos.2023.2022-12-10.

    PMID: 37074094
  8. 8

    Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.

    Martínez-Montoro JI, Pinzón-Martín JL, Damas-Fuentes M, et al.

    Frontiers in endocrinology 2022; (13()):838887 doi:10.3389/fendo.2022.838887.

    PMID: 35498407

This page is for informational purposes only and does not constitute medical advice. A clinical genetics or endocrinology team should interpret your INSR results and guide care for your specific situation.